Publication Name	World Journal of Gastroenterology
Manuscript ID	90663
Country	China

Received	2023-12-10 15:50
Peer-Review Started	2023-12-10 15:50
To Make the First Decision
Return for Revision	2023-12-27 01:19
Revised	2023-12-27 10:39
Second Decision	2024-01-31 02:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-31 05:33
Articles in Press	2024-01-31 05:33
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-20 14:24
Publish the Manuscript Online	2024-02-26 13:28

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era
Manuscript Source	Invited Manuscript
All Author List	Jian-Hong Zhong
ORCID	Author(s) ORCID Number Jian-Hong Zhong http://orcid.org/0000-0002-1494-6396
Funding Agency and Grant Number	Funding Agency Grant Number Specific Research Project of Guangxi for Research Bases and Talents GuiKe AD22035057 National Natural Science Foundation of China 82060510, 82260569
Corresponding Author	Jian-Hong Zhong, Doctor, PhD, Academic Editor, Doctor, Professor, Surgeon, Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. zhongjianhong@gxmu.edu.cn
Key Words	Adjuvant therapy; Hepatocellular carcinoma; Tumor recurrence; Unanswered questions
Core Tip	Several questions need to be addressed by clinical researchers about the use of adjuvant therapy to prolong recurrence-free survival of patients with hepatocellular carcinoma following potentially curative treatment.
Publish Date	2024-02-26 13:28
Citation	Zhong JH. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World J Gastroenterol 2024; 30(8): 806-810
URL	https://www.wjgnet.com/1007-9327/full/v30/i8/806.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i8.806

Full Article (PDF)	WJG-30-806-with-cover.pdf
Full Article (Word)	WJG-30-806.docx
Manuscript File	90663_Auto_Edited-YJP.docx
Answering Reviewers	90663-Answering reviewers.pdf
Audio Core Tip	90663-Audio core tip.aac
Conflict-of-Interest Disclosure Form	90663-Conflict-of-interest statement.pdf
Copyright License Agreement	90663-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	90663-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	90663-Language certificate.pdf
Peer-review Report	90663-Peer-review(s).pdf
Scientific Misconduct Check	90663-Bing-Wang JJ-2.png
Scientific Editor Work List	90663-Scientific editor work list.pdf